dc.creatorFaccone, Diego Francisco
dc.creatorLopez Ruitti, Paula
dc.creatorVazquez, Miryam
dc.creatorGuerriero, Leonor
dc.creatorLucero, Celeste
dc.creatorGagetti, Paula Silvana
dc.creatorCeriana, Paola
dc.creatorCorso, Alejandra
dc.date.accessioned2018-05-31T14:51:08Z
dc.date.available2018-05-31T14:51:08Z
dc.date.created2018-05-31T14:51:08Z
dc.date.issued2016-10
dc.identifierFaccone, Diego Francisco; Lopez Ruitti, Paula; Vazquez, Miryam; Guerriero, Leonor; Lucero, Celeste; et al.; Molecular characterization of a clinical Haemophilus parainfluenzae isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones; Elsevier Science; Infection, Genetics and Evolution; 44; 10-2016; 507-509
dc.identifier1567-1348
dc.identifierhttp://hdl.handle.net/11336/46787
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractWe report an H. parainfluenzae clinical isolate resistant to cefotaxime and with decreased susceptibility to ciprofloxacinrecovered from a patient with cystic fibrosis. The isolate had elevated MICs of ampicillin (256 mg/L), amoxicillin-clavulanate(8 mg/L), cefuroxime (8 mg/L) and cefotaxime (4 mg/L), and showed a β-lactamase-producing amoxicillin-clavulanicacid-resistant (BLPACR) phenotype. A blaTEM-1 plus five amino acid substitutions in the PBP3 were found:Ser385Thr, Val511Ala, Ile519Val, Asn526Lys and Asp551Leu. MIC of ciprofloxacin was 0.5 mg/L, and substitutions ingyrA (Ser84Tyr) and parC (Ser84Phe) genes were detected.
dc.languageeng
dc.publisherElsevier Science
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1016/j.meegid.2016.08.003
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S1567134816303409
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHaemophilus
dc.subjectCefotaxime
dc.subjectFluoroquinolone
dc.subjectPbp3
dc.titleMolecular characterization of a clinical Haemophilus parainfluenzae isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución